期刊文献+

人畜共患病耐药机制

Daug-Resistanting Mechanism of Zoonoses
下载PDF
导出
摘要 利用抗微生物药物预防和治疗人畜共患病,已经取得了长足的进步,但伴随而来的耐药性问题却不容忽视。耐药性产生的机制有生化机制和分子生物学机制,对其耐药性更加深入的认识,为早日战胜微生物耐药性打下了坚实的理论基础。 Great advances have been made in prevention and treatment zoonoses by aid of anti - microbial drugs. But followed drug resistance can't be neglected. There are two resistant mechanism- one is biochemical mechanism, another is molecular biological mechanism. The comprehensively understanding resistance is a solid theoretical basis on conquering microbial resistance.
出处 《实验动物科学与管理》 2005年第3期37-40,共4页 Laboratory Animal Science & Administration
关键词 人畜共患病 耐药性 生化机制 分子生物学机制 zoonoses drug resistance biochemical mechanism molecular biological mechanism
  • 相关文献

参考文献25

  • 1黄瑞,穆荣普.多重耐药伤寒沙门氏菌耐药质粒的研究[J].中华传染病杂志,1990,8(3):139-142. 被引量:19
  • 2谢景超.抗菌药物耐药性的研究进展[J].中国感染控制杂志,2003,2(1):66-69. 被引量:13
  • 3Neu H C. The crisis in antibiotics resistance. Science, 1992.257:1064 ~ 1073.
  • 4Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science, 1994.264:375~ 382.
  • 5Chopral I, Roberts M. Tracycline antibiotics: mode of action,applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev, 2001, 65(2): 232 ~ 260.
  • 6Amabile - Cuevas C F, Chircurel M E. Bacterial plasmils and gene flux. Cell, 1992. 70:189 ~ 199.
  • 7Davies J. Another look at antibiotic resistance. J General Microbiol,1992, 138:1553 ~ 1559.
  • 8Spratt B G. Resistance to antibiotics mediated by target alterations.Science, 1994, 264: 388~393.
  • 9Levin A S. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiuol Infect, 2002, 8(3): 144 ~ 153.
  • 10Lydia B, Lynthia A L, Margie D L, et al. Incidence and characterization of interons, genetic elements mediating multiple drug resistance in avian Escherichia coli. Antimicrob Agents Chemother,1999, 43(12): 2925 ~ 2929.

二级参考文献59

  • 1李立津,王哲,胡文芝.氟哌酸和黄连素对志贺氏菌耐药性质粒消除研究[J].中华传染病杂志,1994,12(1):4-8. 被引量:26
  • 2平松启一.MC-200616 potentiates the activity of β-lactam antibiotics against MRSA[J].日本化学疗法学会杂志,1997,45(9):801-809.
  • 3[1]Cunha B A. Antibiotic resistance[J]. Med Clin North Amer, 2000, 84(6): 1407-1429.
  • 4[2]Cunha B A. Community-acquired pneumonia, diagnostic and therapeutic approach[J]. Med.Clin. North Amer, 2001, 85(1): 43-77.
  • 5[3]Magee J T, Pritchard E L, Fitzgerald K A, et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-1998[J]. Brit. Med J. 1999, 319(7219): 1239-1240.
  • 6[4]Cunha B A. Current concepts in the antimicrobial therapy of community acquired pneumonia [J]. Drugs of Today, 1998, 34(2): 107-123.
  • 7[5]Smith J M, Dowson C G, Spratt B G. Localized sex in bacteria[J]. Nature, 1991, 349: 29-31.
  • 8[6]Cooper R J, Hoffman J R, Bartlett J G, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background[J]. Ann. Inter. Med, 2001, 134(6): 509-517.
  • 9[7]Giamarellou H, Antoniadou A. Antipseudomonal antibiotics[J]. Med. Clin. North Amer, 2001, 85(1): 19-42.
  • 10[8]Segreti J, Levin S. Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin[J]. Amer.J. Med. 1996, 100: Suppl 6A: S45-S51.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部